VEXINE 150 mg
EXTENDED RELEASE TABLETS
registration number
47/1.2/0082
What VEXINE 150 mg contains
VENLAFAXINE.
other ingredients
Ethyl cellulose, hypromellose, methanol, methylene chloride, sugar spheres.
Composition of capsule shell:
Gelatin, iron oxide black (C.I No. 77499), iron oxide red (C.I. No. 77491), sodium lauryl sulphate, titanium
dioxide (C.I. No. 77891).
Composition of ink:
Black iron oxide (C.I. No. 77499), butyl alcohol, dehydrated alcohol, isopropyl alcohol, potassium hydroxide,
propylene glycol, purified water, shellac, strong ammonia solution.
Therapeutic classification
N06AX12.